Mallinckrodt Stock Falls Sharply After a Warning Over Regulatory Dispute 
 

The drugmaker lost over one-quarter of its stock-market value after the company said a dispute with health regulators might cost it $600 million and reduce future sales for Acthar, one of its top-selling products.

 
Apple Changes MacBook Butterfly Keyboard After User Complaints 
 

After customers reported issues with three generations of its Mac laptop keyboard, Apple is changing a component material and expanding its keyboard repair program.

 
Terrible Tuesday for Department Stores 
 

Kohl's and J.C. Penney reported disappointing quarterly results, setting off a tumble in the department-store sector.

 
Huawei Accuses U.S. of Bullying as It Seeks Support From Europe 
 

Huawei denounced U.S. actions against the company as "bullying" and implored European governments to resist American pressure to follow suit in a bid to safeguard one of its most lucrative markets.

 
Wall Street Is Losing Faith in Tesla 
 

As Tesla's shares drop, once-bullish analysts and investors are souring on Elon Musk's company, potentially cutting it off from the capital it needs to survive.

 
Home Depot's Sales Lifted by Larger Customer Transactions 
 

Home Depot's sales rose in the fiscal first quarter, lifted by a rise in the number of customer transactions and stronger spending per visit.

 
'Stranger Things' Brings Back New Coke. Sort of. 
 

Coca-Cola is using one of its biggest failures as a marketing tool, bringing back New Coke for a limited time in a cross-promotion with Netflix's retro science-fiction horror series "Stranger Things."

 
PPG Says It Won't Break Up, Despite Pressure From Activist Investor 
 

PPG Industries won't split its units making building paints and industrial coatings, choosing to forge ahead as a unified company after facing pressure from an activist investor to maximize value in its disparate operations.

 
Merck to Buy Cancer Drug Maker Peloton Therapeutics 
 

Merck agreed to acquire cancer drug developer Peloton Therapeutics for $1.05 billion in cash, adding to a list of deals in 2019 by pharmaceutical companies looking to bolster their cancer treatment portfolios.

 
Boeing Official Played Down Scenario That May Have Doomed Ethiopian Jet 
 

Four weeks after faulty sensor data led a 737 MAX jet to crash in Indonesia last year, a Boeing executive raised and dismissed the possibility of a bird collision triggering a second disaster.

 
 

(END) Dow Jones Newswires

May 21, 2019 15:00 ET (19:00 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.